Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Zolmitriptan
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zolmitriptan 2.5mg tablets
0407041Z0AAAAAA
|
Zolmitriptan | Zolmitriptan | Central Nervous System | 49,989 |
|
Zolmitriptan 2.5mg orodispersible tablets sugar free
0407041Z0AAABAB
|
Zolmitriptan | Zolmitriptan | Central Nervous System | 26,027 |
|
Zolmitriptan 5mg/0.1ml nasal spray unit dose
0407041Z0AAACAC
|
Zolmitriptan | Zolmitriptan | Central Nervous System | 21,720 |
|
Zolmitriptan 5mg orodispersible tablets sugar free
0407041Z0AAADAD
|
Zolmitriptan | Zolmitriptan | Central Nervous System | 11,448 |
|
Zolmitriptan 5mg tablets
0407041Z0AAAEAE
|
Zolmitriptan | Zolmitriptan | Central Nervous System | 3,085 |
|
Zomig 5mg/0.1ml nasal spray 0.1ml unit dose
0407041Z0BBACAC
|
Zomig | Zolmitriptan | Central Nervous System | 1,477 |
|
Zomig 2.5mg tablets
0407041Z0BBAAAA
|
Zomig | Zolmitriptan | Central Nervous System | 1,255 |
|
Zomig Rapimelt 2.5mg orodispersible tablets
0407041Z0BBABAB
|
Zomig | Zolmitriptan | Central Nervous System | 940 |
|
Zomig Rapimelt 5mg orodispersible tablets
0407041Z0BBADAD
|
Zomig | Zolmitriptan | Central Nervous System | 613 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.